Cysts At Spinal Cord Treatment Sites Led To FDA Hold On Geron’s Stem Cell Trial

August 27, 2009

Animals being tested using Geron Corporation’s treatment for spinal cord injury developed cysts at the injury sites, a finding that led the U.S. FDA to place a clinical hold on a planned human trial of the treatment, the Menlo Park, Calif.-based stem cell firm said on August 27. (Stem Cell Research News)